Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 259

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Acute Coronary Syndromes in the GUSTO-IIb Trial: Prognostic Insights and Impact of Recurrent Ischemia

Armstrong, Paul W., Fu, Yuling, Chang, Wei-Ching, Topol, Eric J., Granger, Christopher B., Betriu, Amadeo, Van de Werf, Frans, Lee, Kerry L., Califf, Robert M. · 1998 · Circulation

Abstract

Background —Recurrent ischemia after an acute coronary syndrome portends an unfavorable outcome and has major resource-use implications. This issue has not been studied systematically among the spectrum of patients with acute coronary presentations, encompassing those with and without ST-segment elevation. Methods and Results —We assessed the 1-year prognosis of the 12 142 patients enrolled in the GUSTO-IIb trial by the presence (n=4125) or absence (n=8001) of ST-segment elevation. This latter group was further categorized into those with baseline myocardial infarction (n=3513) or unstable angina (n=4488). We also assessed the incidence of recurrent ischemia and its impact on outcomes. Recurrent ischemia was significantly rarer in those with ST-segment elevation (23%) than in those without (35%; P <0.001). Mortality at 30 days was greater among patients with ST-segment elevation (6.1% versus 3.8%; P <0.001) but less so at 6 months; by 1 year, mortality did not differ significantly (9.6% versus 8.8%). Patients with non–ST-segment-elevation infarction had higher rates of reinfarction at 6 months (9.8% versus 6.2%) and higher 6-month (8.8% versus 5.0%) and 1-year mortality rates (11.1% versus 7.0%) than such patients who had unstable angina. Conclusions —Refractory ischemia was associated with an approximate doubling of mortality among patients with ST-segment elevation and a near tripling of risk among those without ST elevation. This study highlights not only the substantial increase in late mortality and reinfarction with non–ST-segment-elevation infarction but also the opportunities for better triage and application of therapeutic strategies for patients with recurrent ischemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.98.18.1860

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 259

Metadata

Authors
Armstrong, P. W., Fu, Y., Chang, W.-C., Topol, E. J., Granger, C. B., Betriu, A., Van de Werf, F., Lee, K. L., & Califf, R. M.
Venue
Circulation
Published
1998-11-03
Volume
98
Issue
18
Pages
1860-1868
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2170218245
Cited by
259
References
19
FWCI
9.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute Coronary Syndromes in the GUSTO-IIb Trial: Prognostic Insights and Impact of Recurrent Ischemia. https://app.cochat.ai/papers/10.1161/01.cir.98.18.1860
The paper
Armstrong, P. W., Fu, Y., Chang, W.-C., Topol, E. J., Granger, C. B., Betriu, A., Van de Werf, F., Lee, K. L., & Califf, R. M. (1998). Acute Coronary Syndromes in the GUSTO-IIb Trial: Prognostic Insights and Impact of Recurrent Ischemia. Circulation. https://doi.org/10.1161/01.cir.98.18.1860

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.